MODIFIZIERTE SACCHARIDE

European patent · EP2118145 · In force

Register entry

Publication number
EP2118145
Application number
EP08737594
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 11, 2008
Published
Nov 18, 2009
Granted
May 17, 2017
Protection ends at the latest
Jan 10, 2028
Next annual fee due
Jan 31, 2027
IPC classes
C08B 37/00 (2006.01)
A61K 39/095 (2006.01)
A61K 47/50 (2017.01)
C07H 13/00 (2006.01)
Priority
GB 0700562 11.01.2007
PCT application
PCT/IB2008/001116 11.01.2008
PCT publication
WO2008/084411 17.07.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Jun 15, 2017

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 15.06.2017

  6. May 17, 2017

    Granted

    Published in Swissreg on 17.05.2017

Parties

Holder

GlaxoSmithKline Biologicals SA

Rue de l'Institut 89, 1330 Rixensart, BE

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

BARDOTTI, Angela

53100 Siena, IT

BERTI, Francesco

53100 Siena, IT

COSTANTINO, Paolo

53100 Siena, IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.